this is hero image

Long term is life changing.

Eversense E3 is gives you the reliable data you need over longer periods of time, so you can focus on managing your diabetes, and your daily life. See what real people have to say.

Real Impact, Proven Results.

By reducing their device burden, those who have switched to Eversense have gained more confidence and control over their diabetes self-management.

85%

Reported improved confidence over control of their diabetes1

86%

Reported less day-to-day burden1

80%

Were more motivated to keep up with diabetes management1

84%

Of users would choose to be inserted again1

5 simple questions to see if you’re
ready for a long-term CGM.

1. Does the adhesive on your current CGM irritate your skin?

 

2. Tired of false lows/false readings or gaps in data?

 

3. Want to occasionally remove your CGM without wasting a sensor?

 

4. Do your CGM alerts sometimes disrupt those around you?

 

5. Would you prefer only 2 sensor changes a year?

 

If you answered yes to any of these questions, then Eversense E3 may be the ideal CGM for you.

this is 50 | 50 image

Looking for more reasons to switch?

Here are a few ways Eversense E3 outlasts and outperforms short-term CGMs. 

Eversense E3
Other CGMs
Sensor life
6 months
7-14 days
Sensor changes per year
2
26-52
Day 1 warmup periods
2
26-52
Insertion by trained professional
Yes
No
Transmitter can be removed and put back on without wasting a sensor*
Yes*
No
On-body alerts
Yes
No
Silicone-based fresh daily adhesive for comfort2
Yes
No
Dianne

“Since using Eversense, I worry much less about having a severe low glucose event. I used to worry about it every day because I knew one was coming.”

Chris

“Eversense helps me with diabetes management in general because I wear my CGM more… My time in-range has gone up, my A1C has gone down, and my quality of life has improved.”

Matt

“The fact that I can be [presenting in a meeting] and have the on-body vibe alerts tell me if I’m going low or high and be able to respond without broadcasting it has been really helpful and really freeing for me.”

Paul

“I do a lot of work in the outdoors, where a traditional CGM may not survive. It’s nice to know that I can remove the transmitter to get through the rougher terrain and put it right back on when I’m done.”

Mary

“I trust what my Eversense tells me. To have accurate numbers in my life means peace of mind. I can trust the system, and I don’t have to second-guess everything.”

image
image
image
image
image

Join us.

Connect with people within the Eversense community, dive deeper into their stories and access additional resources around long-term diabetes management.

COMMUNITY
this is 50 | 50 image

Learn More

E3 Long Term Exceptional Accuracy

Only the Eversense E3 CGM System offers 6 months of exceptional accuracy with a single sensor.

READ MORE

Predictive and Rate of Change Alerts

Even with the best management plan, diabetes can still be unpredictable at times. In addition to the Glucose Level Alerts, your Eversense E3 CGM System has two other alert settings which when turned ON, may help you manage sudden or unexpected changes in glucose levels: Predictive Alerts and Rate of Change Alerts.

READ MORE

Glucose Data for You

Access your In-App Reports in the Eversense app to better understand your glucose patterns and history and learn how to easily share it with your health care provider.

READ MORE

Trend Arrows and Treatment Decisions

Stay on top of your diabetes management knowing you get exceptionally accurate1 readings, even with hypoglycemia, and learn how to use trend arrows.

READ MORE

Want to see if you
qualify?

Our short quiz will ask about your insurance coverage, your insulin usage, and what benefits you’re looking for in a CGM.

If you’re ready, click below and let’s see if Eversense is right for you.

* There is no glucose data generated when the transmitter is removed

1. Barnard et al. Acceptability of Implantable Continuous Glucose Monitoring Sensor. Journal of Diabetes Science and Technology 2018, Vol. 12(3) 634–638.
2. Deiss, D., et al. (2020). Real-world safety of an implantable continuous glucose sensor over multiple cycles of use: A post-market registry study. Diabetes Technology and Therapeutics, 22(1), 48–52. https://doi.org/10.1089/dia.2021.0182.

The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more. For safety information click here.

Eversense, Eversense E3 Continuous Glucose Monitoring and the Eversense logo are trademarks of Senseonics, Incorporated. Ascensia, and the Ascensia Diabetes Care logo are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.



Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.

 

PP-SENS-E3-GBL-0061